Skip to content

Effect of Luteal Phase Surgery on Postoperative Depressive Symptoms in Female Breast Cancer Patients and Its Biological Mechanism

Effect of Luteal Phase Surgery on Postoperative Depressive Symptoms in Female Breast Cancer Patients and Its Biological Mechanism

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123185
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-04-22
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Luteal Phase group:None
Non-luteal Phase group:None

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily join this study and sign the informed consent form; 2. Age 18-55 years old; 3. ASA grade I-III; 4. Female patients; 5. Non-amenorrhea; 6. In the luteal phase or non-luteal phase (excluding menstruation); 7. Mild to severe depressive symptoms (11 points< MADRS< 35 points); 8. Elective unilateral radical breast cancer resection is planned.

Exclusion criteria

Exclusion criteria: 1. Patients with preoperative chemoradiotherapy or endocrine therapy and patients with secondary surgery (recurrence or reconstruction); 2. BMI >30kg/m ²; 3. Mental illness, bipolar disorder or medical history; 4. History of antidepressant treatment within 2 weeks; 5. Patients with obvious abnormal liver and kidney function before surgery; 6. Unable to cooperate with the investigator for any reason: such as hearing or visual impairment, language comprehension disorder, mental illness, etc; 7. History of drug dependence or current pregnancy or breastfeeding; 8. Plan to enter the ICU before surgery; 9. Have participated in other researchers.

Design outcomes

Primary

MeasureTime frame
Incidence of depression 3 days after surgery;

Secondary

MeasureTime frame
The incidence of depression at 1 day after the operation, 7 days after the operation, 4 weeks after the operation and 12 weeks after the operation;Severity of depression;The incidence of severe postoperative pain;Changes in blood BDNF content;Intraoperative electroencephalographic features;The number of additional postoperative analgesics;Postoperative hospital stay days;

Countries

China

Contacts

Public ContactMei Bin

The First Affiliated Hospital of Anhui Medical University

mb85doc@yeah.net+86 135 0560 3810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026